C
ollagen-induced arthritis (CIA) l in mice is an experimental animal model bearing similarities to human rheumatoid arthritis. CIA is typically induced by immunizing geneticaUy susceptible mice with native type II collagen (CII) in CFA (1) . Both humoral (2) and cellular (3) immunity against CII can be detected in this inflammatory polyarthritis. Although anti-CII antibodies contribute to the arthritogenic process (4), severe and chronic arthritis stems from activation of CII-reactive T cells (5, 6) responsible for the release and/or induction of proinflammatory cytokines such as IFN-3', TNF-ot, and IL-1 (7) (8) (9) (10) .
Previous studies established that susceptibility to CIA is associated with genes of the MHC, in particular gene products residing within the H-2A subregion (1) . Mouse strains that bear the H-2q or H-2 r haplotype can consistently develop CIA, whereas strains bearing other haplotypes such as H-2 b or H-2 a are highly resistant (1). However, among the H-2q strains, SWR and AUAsJ fail to develop CIA (11, 1 Abbreviations used in this paper: CIA, collagen-induced arthritis; CII, native type II collagen. 12). Likewise, RIIIs/J (H-2 r) mice are similarly CIA resistant (13) . Work by Behlke et al. (14) showed that SWR mice were among four mouse strains that possess a deletion of ~50% of their Va genome. A similar deletion was subsequently detected in the AUAsJ strain (12) . These strains have been designated as V~ n haplotype and lack the members of the V~8 and 5 gene families as well as the V~9, 11, 12, and 13 gene segments (14) . In addition, Haqqi et al. (15) showed that RIIIs/J animals also possess a highly truncated TCR V~ genotype composed of the genes deleted in V~ n mice along with four additional V~ genes (V~6, 15, 17, and 19) . This unique deletion has been designated V~ c and encompasses ~70% of the V~ genome.
To determine whether the TCR V~ deletion in SWR contributes to CIA resistance, gene complementation studies were undertaken. Analysis of F2 progeny from a cross between the SWR strain and B10 mice, which bear the CIAresistant H-2 b haplotype but possess the wild-type V~ b genotype, revealed that these offspring were CIA susceptible and a strong correlation between arthritis susceptibility, possession of the Va b allele, and homozygosity for the H-2q haplotype was observed (16) . A dominant role for C5 deficiency contributing to CIA resistance in the SWR strain was eliminated by the observation that offspring of a cross between SWR mice and A/Sn animals (Vo b, C5 deficient) remained susceptible to CIA (17) . Taken together, these findings suggested that the V~ ' genotype may confer resistance to CIA in SWR and other H-2q mice.
Interestingly, subsequent studies examining the role of the V~ ~ deletion in CIA resistance have been controversial. Spinella et al. (18) and Andersson et al. (19) reported no correlation between CIA susceptibility and V0 haplotype in arthritic F2 progeny of a DBA/1 x SWR cross. It is unclear whether genes provided by the DBA/1 genome, a strain prone to the development of spontaneous arthritis (20) , contributed to these observations. Attempts to modulate arthritis induction in DBA/1 mice, by depleting T cells using V~ TCRs encoded within the VO a deletion, have led to conflicting results (21) (22) (23) . Finally, Mori et al. (24) demonstrated that in the expression of a transgenic TCR/5 chain, derived from a CII-reactive arthritogenic T cell clone, mice failed to confer CIA susceptibility in SWR mice. However, expression of this transgene enhanced CIA development in (DBA/1 x SWR)F1 mice. This observation supports a role for TCR V~ genes in arthritogenesis. In addition, the varying effects of this V~ TCR transgene on CIA, in the context of different genetic backgrounds, underscored the multiple genetic control of this autoimmune disease.
Given the polygenic nature of CIA in mice, it is clear why previous gene complementation and transgenic studies have failed to unequivocally determine the influence of TCR V~ gene deletions on the induction and development of arthritis. To directly address this issue, it is necessary to derive strains of CIA susceptible mice congenic for the three known V0 haplotypes. Such an approach eliminates the contribution of background genes in the experimental outcome, a problem inherent in gene complementation analysis. Thus, we have developed lines of B10.Q (H-2q) mice congenic for the V~ a and Va c genotype. We report here that, in the B10.Q strain, possession of the V~ ~ TCR gene deletion has no influence on the induction or development of CIA. However, B10.Q mice congenic for the V~ c genotype were highly resistant to CIA. Our studies demonstrate that, in association with certain background genes, TCK V~ haplotypes can indeed play a major role in CIA development and illustrates the necessity of particular TCR V~ genes in the generation of arthritogenic responses against CII.
Materials and Methods
Mice. All mice used in this study were bred and maintained in the Immunogenetics Mouse Colony of the Mayo Clinic. Breeding of the TCR Va congenic lines was achieved as detailed in Fig. 1 . Mice of both sexes were used in this study and were 8-12 wk of age at the beginning of the experiment.
Induction of CIA. Native bovine CII, isolated and purified as previously described (1), was dissolved overnight at 4~ in 0.01 N acetic acid and then emulsified at a 1:1 ratio with CFA (Mycobacteriura tuberculosis strain H37Ra; Difco Laboratories Inc., Detroit, MI). Mice were immunized with 100/xl (containing 100/~g bovine CII) of cold emulsion intradermaUy, at the base of the tail. All mice were monitored three to four times a week for CIA development over a 16-wk period. Arthritic severity was determined as detailed previously (1) using a scoring system for each paw as follows: 1, redness or swelling in paw or toes; 2, severe swelling and/or joint deformity; 3, joint ankylosis. The arthritic score per paw was summed to give a maximal possible score of 12 for each individual animal. The mean arthritic score/group was determined using arthritic mice only.
Flow Cytometric Analysis. Determination of normal Vo TCR expression in B10.Q B10.Q-Vo a, and B10.Q-Vo c mice was achieved as follows: briefly, splenic T lymphocytes were purified by incubation over a nylon wool column using standard procedures (25) . The nonadherent cells were washed extensively in phosphatebuffered saline containing 1% bovine serum albumin and 0.1% sodium azide. Approximately 106 cells were then incubated with one of the following Va TCR-specific mAbs: B20.6, rat anti-Va2 (26) Statistical Analysis. The incidence of arthritis between groups was determined using X 2 analysis. The mean day of arthritis and arthritic severity between groups was determined using the nonparametric Mann-Whitney U test.
Results

Generation of BIO.Q-V~ Congenic
Mice. The goal of this study was to directly address the role of V~ TCR gene deletions in the induction and perpetuation of CIA. Thus, congenic mice of the B10.Q background were developed which possessed either the truncated Vfl 9 or V~c genotypes. Fig. 1 illustrates the breeding strategy employed to derive the V~ TCR congenic lines. Briefly, V0b-bearing B10.Q mice were mated with C57L (V~") animals and the F1 progeny were backcrossed to B10.Q. Offspring of the (B10.Q x C57L)F1 x B10.Q cross were typed for MHC haplotype using standard hemagglutination techniques, and "CO haplotype by flow cytometric analysis of PBL using the V~8.2-specific mAb F23.2. Mice that typed as H-2q/q, V~/b were selected and backcrossed to the B10.Q strain for 10 generations. After the 10th backcross, V~ "/b offspring were intercrossed and the VB ~/' progeny selected to establish the congenic B10.Q-V~ ~ line. Establishment of the B10.Q-V~ c line was achieved using a similar strategy in which Vat-bearing RIIIs/J mice were initially mated with B10.Q mice and the Va b/c offspring selected during backcross generations to B10.Q.
Analysis of Pen'pheral V~ TCR Repertoire in BIO.Q-Vn Congenie Mice.
Given the introduction of truncated Vt~ genotypes into B10.Q mice, the expression of V0 TCK on splenic T cells in B10.Q, B10.Q-Vo ~, and B10.Q-Vo ~ animals was determined. Using a panel of Vo TCR-specific mAb, flow cytometric analysis revealed that, in general, both B10.Q-Vo a and B10.Q-Vo c mice displayed an increase in expression of nondeleted Va TCR (Table 1) . Interestingly, introduction of the functional Vo17a gene in B10.Q-V~ a mice led to a high expression of V~17 + T cells in the CD4 subset. No difference was observed in the CD4/CD8 ratio between the B10.Oo B10.Q-Vo ', and B10.Q-V~ c strains (data not shown). In both the B10.Q-Vo" and B10.Q-Vo c strains, the panel of VO TCR-specific mAbs used for analysis accounted for "~38 and 21% of the total CD4 + and CD8 + T cell populations, respectively. In contrast, 82 and 67% of the Va-bearing CD4 + and CD8 + T cells could be accounted for in B10.Q mice. Therefore, a majority of Vt~ TCR genes that were not quantitated by flow cytometry (Vo 1, 3, 10, 15, 16, 18, 19 , and 20) appear to be used by the congenic B10.Q-Vt# and B10.Q-V~ ~ mice to shape their respective peripheral TCR repertoires.
CIA Susceptibility in BIO.Q-V~ Mice.
To determine the influence of the V;r haplotype in H-2q-restricted CIA, the susceptibility of congenic B10.Q-Vo a mice to arthritis induction was evaluated. Fig. 2 shows that, after immunization with bovine CII, B10.Q-V~" mice remained susceptible to CIA. Analysis of 23 animals demonstrated that the B10.Q-V~ ~ strain displayed no noticeable difference in susceptibility, disease onset, or arthritic severity when compared with BIO.Q mice. Thus, in BIO.Q mice, possession of the VO a genotype does not affect the induction or development of CIA.
Arthritis Susceptibility in BIO.Q-V~" Mic~
To test the effect of a highly truncated V~ TCK genome on H-2q-restricted CIA, the susceptibility of B10.Q-Va c mice to arthritis induction was also determined. In contrast to the B10.Q-Va a strain, B10.Q-V~ r mice were markedly resistant to CIA (Fig.  3 ). After immunization with bovine CII, only 4 of 13 animals developed arthritis over the 16-wk observation period, with 2 of the 4 arthritic mice displaying a transient disease. In addition, Fig. 4 illustrates that, of the B10.Q-V~ ~ mice that developed CIA, arthritic severity was mild compared with B10.Q animals. These findings show that the highly truncated V~ c genotype can dramatically alter arthritis susceptibility in B10.Q mice. Figure 3 . Kesistance of B10.Q-V0 ~ mice to CIA after immunization with bovine CII. B10.Q {solid line, n = 10) and B10.Q-V0 ~ mice (broken line, n = 13) were immunized with 100 #g bovine CII in CFA and monitored regularly for the development of CIA. (Fig. 6) . Therefore, these data show that the early depletion of Vfl6 + T cells can modulate arthritogenesis in B10.Q-V~ ' mice. In addition, these findings implicate a role for Vfl6-bearing T cells in the recognition of arthritogenic epitopes on CII and the eventual induction of CIA.
Modulation of CIA Development in BIO.Q-V~ ~ Mice Upon
Discussion
It is known that susceptibility to CIA in mice is dependent upon possession of the appropriate MHC haplotype (1) as well as CII specific arthritogenic T cells (5, 6 ). The T cell dependence of this disease has led to the suggestion that the population of T cells specific for CII may use a limited repertoire of TCR V~ and Va genes. Indeed, a concerted effort to test this hypothesis has been put forth by numerous investigators. However, unequivocal demonstration of a restricted TCR repertoire in CIA has remained elusive. Clearly, the polygenic nature of CIA, as well as species specific differences in the arthritogenicity of CII (40), have hampered attempts at reconciling experimental discrepancies among various laboratories. Such discrepancies are best depicted in experiments devoted to examining the role of the Va a gene deletion in CIA (16) (17) (18) (19) . Initial studies by Banerjee et al. (16) , using progeny of a B10 x SWR cross, suggested that possession of the Va ~ genotype results in CIA resistance. In contrast, studies by Spinella et al. (18) and Andersson et al. (19) , using DBA/1 x SWR crosses, found no correlation between the Vr haplotype and CIA resistance. Therefore, it was the goal of this study to develop TCR V~ congenic B10.Q mice in an effort to directly examine the role of V~ haplotypes on CIA. Our data show that in the B10.Q strain, possession of the Vo a genotype has no influence on CIA susceptibility. However, the arthritogenic TCR V~ repertoire displays only a limited degree of flexibility since introduction of the severely truncated Va c genotype renders B10,Q mice resistant to CIA. Development of TCR Va congenic mice allows one the opportunity to not only examine the influence of such gene deletions in autoimmune diseases, but also a chance to explore the effect of V~ haplotypes on TCR repertoire development in a fixed genetic background. In the B10.Q background, both congenic Given the current discrepancies surrounding the role of the V~ ~ genotype in CIA resistance in SWR (H-2q) mice, it was of great interest to determine the susceptibility of B10.QVa a mice to CIA. After immunization with bovine CII, B10.Q-V~ a mice displayed no difference in arthritis susceptibility, onset or severity when compared with prototype B10.Q animals (Fig. 2 ). This finding clearly shows that in B10.Q mice, possession of the V~ a genotype alone is insufficient to cause CIA resistance.
Previous studies from our laboratory demonstrated that offspring of a (C57L[V~ "] x SWR)FI x C57L cross failed to develop CIA (17) , thereby further implicating the Va ~ genotype in CIA resistance. In light of our current findings in B10.Q-Va ~ mice, it is dear that additional genetic factors, possibly in combination with the Va ~ haplotype, render some H-2q animals CIA resistant. It is possible that C57L mice share an unidentified genetic lesion with the SWR strain that contributed to the previous observations. Alternatively, the presence of the heterozygous H-2 b/q haplotype in (C57L x SWR)~I x C57L animals may have led to the presenta- Although the B10.Q-Vtr strain displayed a similar pattern of arthritis susceptibility to B10.Q mice, one cannot say a priori that the mechanisms underlying the arthritogenic response is identical in both strains. To date, two H-2q-restricted T cell epitopes on the CII molecule, residues 181-209 and 260-270, have been identified which may play a role in CIA (41, 42) . It is possible that B10.Q-Va ~ T cells respond to only one of the two determinants, but, this response may still be sufhcient to induce arthritis (Fig. 7) . A second possibility is that introduction of the Va ~ genotype may lead to the recognition of a distinct determinant within the immunodominant peptide, as previously shown for H-2 drestricted responses against the 110-121 peptide of sperm whale myoglobin (43) (44) (45) . Finally, it is also possible that the genetic backgrounds in the H-2q-bearing SWB,, DBA/1, and B10.Q strains generate different self peptides that may modulate and/or influence potential CII-reactive T cells. Further studies are required to delineate the nature of CII-specific T cell responses in B10.Q-Va" mice.
In contrast to the V~ ~ haplotype, introduction of the highly truncated Va c genotype in B10.Q mice resulted in a marked resistance to CIA (Fig. 3) . The differential susceptibility between the B10.Q-V~ ~ and B10.Q-V~ ~ strains provided an opportunity to map candidate VO TCR genes involved in the arthritogenic response. In vivo depletion of Va6 + T cells in B10.Q-Va' animals led to significant delay in arthritis onset compared with control mice (Fig. 5) . Thus, in the B10.Q background, Va6 + T cells participate in the induction of CIA. This finding is indirectly supported by two lines of experimental evidence. First, offspring of a (B10.Q • BALB.D2.mls')p1 cross, which lack Va6 + T cells due to a Mls-l~-mediated clonal deletion, displayed a reduced incidence of CIA (38) . Second, Haqqi et al. (39) demonstrated a retention of Va6 mRNA transcripts arthritic joints of B10.Q mice. Molecular analysis of Va6 alleles between V~ ~-and Vab-haplotype mice revealed only minor differences (46) suggesting that our findings using B10.Q-Va ~ mice are compatible with the aforementioned observations in Va b strains.
The demonstration that V~6 + T cells contribute to CIA in B10.Q animals is in contrast to previous studies using another H-2q strain, DBA/1. Chiochia et al. (21), Horn et al. (22) , and Goldschmidt et al. (23) , reported no effect on CIA induction in DBA/1 mice after the in vivo elimination of Va6 * T cells. However, analysis of CII-reactive T cell hybridoma clones from DBA/1 mice immunized with CII revealed a predominant usage of Val +, Va8.2 +, and Va6 + TCRs (47) . On balance, our findings, in association with the previous studies, illustrate that a multiplicity of factors are responsible for shaping the arthritogenic TCR repertoire. Although our experimental approach using congenic mice precludes identification of such putative factors, our data does shed light on understanding the influence of Va TCR genotypes in CIA, Yet, one must note that even a small propor- tion of B10.Q-Vr c mice still retained the ability to develop arthritis. Thus, identifying those factors which act in concert with TCR Va genes requires thorough investigation. Previous studies suggest that candidate factors may include species specific differences in CII arthritogenicity (40) and TCR V,~ genotypes (48) . Additionally, the identification of non-MHC, non-TCR genetic influences in CIA, as previously reported for the nonobese diabetic mouse model of type I diabetes (49) (50) (51) remains to be determined. Clearly, elucidation of these influences is needed for a complete understanding of the mechanisms responsible for arthritogenesis.
V13 b Mice
In closing, this study is the first attempt to directly address the influence of TCR Va genotypes on murine CIA. The use of TCR V~ congenic mice not only allows a means to test the role of these genotypes in the generation of arthritis, but also examines the contribution of truncated V~ genomes in the formation of the arthritogenic TCR repertoire. Moreover, the development of TCR Va congenic strains on a variety of H-2 haplotypes will enable investigators to address similar questions in other models of autoimmune disease. Answers to such issues may lead to a better understanding of the mechanisms underlying the development and triggering of autoimmune responses.
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